Price target
440.880.000.00%
The 11 analysts offering 1 year price forecasts for IX1 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 16 analysts giving stock ratings to IX1 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
IX1 EPS for the last quarter is 2.37 CHF despite the estimation of 2.27 CHF. In the next quarter EPS is expected to reach 2.16 CHF. Track more of IDEXX LABORATORIES financials and stay on top of what is up with the company.
In the next quarter IDEXX LABORATORIES revenue is expected to reach 840.70 M CHF. Check out IDEXX LABORATORIES revenue and earnings and make informed decisions.
According to analysts, IX1 price target is 440.88 CHF with a max estimate of 499.89 CHF and a min estimate of 384.19 CHF. Check if this forecast comes true in a year, meanwhile watch IDEXX LABORATORIES stock price chart and keep track of the current situation with IX1 news and stock market news.
We've gathered opinions of 16 analysts rating IX1 stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.